Amy Chadwick

Lecturer

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Richard Rainbow

Senior Lecturer

University of Liverpool

UNITED KINGDOM

View details

Rebecca Jensen

Lecturer

University of Liverpool

UNITED KINGDOM

View details

Neill Liptrott

Reader in Pharmacology and Immunocompatibility

University of Liverpool

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amy Chadwick

Research Interests

Explore related searches

Contact this professor

Articles (11)

Assessing the mitochondrial safety profile of the molnupiravir active metabolite, β-d-N4-hydroxycytidine (NHC), in the physiologically relevant HepaRG model

The generation of HepG2 transmitochondrial cybrids to reveal the role of mitochondrial genotype in idiosyncratic drug-induced liver injury

Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis

Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection.

Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1

The Role of Mitochondrial DNA Variation in Drug Response: A Systematic Review

Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteers

Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models.

The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine

Safety perspectives on presently considered drugs for the treatment of COVID‐19

Investigating the importance of individual mitochondrial genotype in susceptibility to drug-induced toxicity

Collaborators (3)

Richard Rainbow

Rebecca Jensen

Neill Liptrott

Make your next move.